Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
DRUG-ABUSE TREATMENT RETENTION AND PROCESS EFFECTS ON FOLLOW-UP OUTCOMES
Autore:
SIMPSON DD; JOE GW; ROWANSZAL GA;
Indirizzi:
TEXAS CHRISTIAN UNIV,INST BEHAV RES,TCU BOX 298740 FT WORTH TX 76129
Titolo Testata:
Drug and alcohol dependence
fascicolo: 3, volume: 47, anno: 1997,
pagine: 227 - 235
SICI:
0376-8716(1997)47:3<227:DTRAPE>2.0.ZU;2-5
Fonte:
ISI
Lingua:
ENG
Soggetto:
METHADONE-MAINTENANCE; TREATMENT PROGRAM;
Keywords:
METHADONE MAINTENANCE; MOTIVATION; TREATMENT PROCESS; TREATMENT RETENTION; FOLLOW-UP OUTCOMES;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Science Citation Index Expanded
Citazioni:
32
Recensione:
Indirizzi per estratti:
Citazione:
D.D. Simpson et al., "DRUG-ABUSE TREATMENT RETENTION AND PROCESS EFFECTS ON FOLLOW-UP OUTCOMES", Drug and alcohol dependence, 47(3), 1997, pp. 227-235

Abstract

After finding that retention in methadone treatment for a year or longer was a highly significant predictor of patient outcomes following discharge, measures of pretreatment motivation and early therapeutic engagement were examined as predictors of program retention. Personal interviews were conducted with a sample of 435 patients 12 months after discharge from three methadone treatment programs. Logistic regressionresults showed several patient attributes-i.e. over 35, lower injection frequency before admission, and higher motivation for treatment-were each associated with twofold increases in the likelihood of having favorable follow-up outcomes on illicit drug use, alcohol use, and criminal involvement. Patients staying in treatment a year or longer, however, were nearly five times more likely to have better outcomes. Further analyses established that length of treatment stay was predicted byhigher patient motivation at intake and early program involvement. The findings suggest that more comprehensive models of patient attributes, therapeutic process, and environmental influences are needed, and that treatment enhancement efforts should focus on such during-treatment measures as interim criteria for improving posttreatment outcomes. (C) 1997 Elsevier Science Ireland Ltd.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/09/20 alle ore 06:36:31